Samia Hassan El-Shishtawy
Quick facts
Phase 3 pipeline
- Astrazenica vaccine · Immunology / Infectious Disease
The AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) uses a replication-deficient chimpanzee adenovirus vector to deliver the SARS-CoV-2 spike protein gene, triggering immune responses against the virus.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: